Tumor immune cells (PTPRC/CD45+) also consisted of B cells (MS4A1/CD20+), plasma cells (XBP1+), macrophages (CD14+), dendritic cells (CD80+, CD86+), and mast cells (TPSAB1+). This evidence concerns the gene MS4A1 and neoplasm.